T. Sasaki

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

Y. Ohya, N. Katoh, H. Murota, 2021, JAAD international.

Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study

K. Yamasaki, Nobukazu Hayashi, E. Raymundo, 2023, Dermatology and Therapy.

Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study

Y. Ohya, N. Katoh, H. Murota, 2022, Dermatology and Therapy.

[A clinical trial of SM-4300 against severe infections in surgery].

K. Matsumoto, M. Fujimoto, K. Sakai, 1985, The Japanese journal of antibiotics.